Pre-IPO Biocytogen Pharmaceuticals - The Novel Development Model Offset the Pipeline's Shortcomings
We analyzed the unique development strategy of Biocytogen, and also pointed out the concerns on its pipeline. However, its business model is hard...
474 Views
Biocytogen (百奥赛图) Pre-IPO: Peer Comparison and Prelim Valuation for Animal CRO
We will compare Biocytogen's business with its close animal CRO peers which filed listing applications to list on the A-share market recently, and...
334 Views
ECM Weekly (17th October 2021) - SG Lottery, GQG, Judo Bank, Vulcan Steel, Biocytogen, Kakao Pay
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
620 Views
Biocytogen (百奥赛图) Pre-IPO: From Animal CRO to Biotech
We look at Biocytogen's main business line of animal CRO (gene-edited mice) and also its two core assets YH003 and YH001.
421 Views